AFAP1 and esophageal adenocarcinoma: Early studies showed markedly upregulated expression levels of AFAP1-AS1 in Barrett’s esophagus and esophageal adenocarcinoma, with AFAP1-AS1 silencing by small interfering RNA leading to inhibited proliferation and colony-forming ability, induced apoptosis, and reduced cell migration and invasion [24].